Second, we have included an additional, possibly more robust statistical analysis to compare the evolution of non-invasive surrogates of portal hypertension (PLT, LSM, VWF, and VITRO score) in cohort B. This form of analysis (ANCOVA) also considered the BL values of the respective variables and thus, directly accounted for pre-treatment differences. Here, VWF is linked to portal hypertension.